Moscow-ALSHARQIYA November 27: Russia announced on Friday the conclusion of an agreement with the Indian "Hetero" pharmaceutical group to produce more than one hundred million annual doses of the Russian "Sputnik-V" vaccine against the emerging corona virus.
The Russian sovereign fund, which financed the development of the vaccine, said that the Hetero Group agreed to produce more than a hundred million doses of the vaccine in India, indicating that the vaccine production process will begin in early 2021.
The statement indicated that clinical trials of the vaccine in the second and third stages are currently underway in India.
- AlSharqiya Programs
- AlSharqiya News Programs
Al Shaqriya Live
Al Sharqiya News Live
- Tv Schedule